Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

DARE Dare Bioscience Inc

-0.0346 (-7.61%)
Pre Market
Last Updated: 05:05:02
Delayed by 15 minutes


Draw Mode:

Volume 4,000
Bid Price 0.415
Ask Price 0.4785
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Dare Bioscience Inc DARE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0346 -7.61% 0.42 05:05:02
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
9 4,000 - 0.27 - 1.02
Last Trade Time Type Quantity Stock Price Currency
05:04:57 formt 2,000 $ 0.42 USD

Dare Bioscience Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
44.35M 98.56M - 2.81M -30.16M -0.31 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Dare Bioscience News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No DARE Message Board. Create One! See More Posts on DARE Message Board See More Message Board Posts

Historical DARE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.42990.630.377750.48448741,054,784-0.0099-2.30%
1 Month0.2880.630.280.35508391,274,9820.13245.83%
3 Months0.580.630.280.373499695,679-0.16-27.59%
6 Months0.330.630.270.366137671,6300.0927.27%
1 Year0.99281.020.270.4544328469,481-0.5728-57.70%
3 Years1.302.510.271.611,844,880-0.88-67.69%
5 Years0.88273.850.271.641,494,178-0.4627-52.42%

Dare Bioscience Description

Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, primarily in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream.

Your Recent History

Delayed Upgrade Clock